创新药“多点开花” “癌症慢病化”深刻影响医药产业

新华财经
3 hours ago

国家药监局最新数据显示,今年上半年我国批准38个1类创新药上市,其中11个新靶点、新机制药物全部为国产自主研发。在这11个具备全球首创潜力的创新药中,抗肿瘤药物占4个。随着更多抗肿瘤新药获批上市,靶向、免疫、细胞治疗等新疗法不断取得突破,越来越多癌症患者的生存周期从“按周、按月计算”拉长至“按年甚至十年计算”。医学技术进步推进癌症慢病化,也对医药产业发展产生显著影响。  “癌症慢病化”对医药行业...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10